Fostamatinib disodium hexahydrate
Webfostamatinib disodium hexahydrate Sponsor: Rigel Pharmaceuticals, Inc. Approval Date: April 17, 2024 Indication: For the treatment of thrombocytopenia in adult patients with … WebR788 disodium为我司主打产品，我司该产品用户遍及全国各院校，纯度高，价格优，以完善的产品渠道、优质的客户服务,节约您的每一份经费，欢迎来电咨询订购。 参数规格 产品名称：R788 disodium 产品编号：EY0465 C A S 号：1025687-58-4 别 名
Fostamatinib disodium hexahydrate
Did you know?
WebHomepage TAVALISSE® (fostamatinib disodium hexahydrate) tablets A different approach to managing chronic ITP TAVALISSE is an oral medicine that can help you manage chronic immune thrombocytopenia (ITP) by protecting your platelets from destruction Learn how … A different way to manage chronic ITP. Important Safety Information What is … Chronic ITP can be a serious condition and should be managed properly What is ITP? … TAVALISSE TOGETHER—partnering with you throughout your treatment journey. … A different way to manage chronic ITP. How often will my healthcare provider monitor … Setting Your Treatment Goals. Treatment success is about more than just an … By providing your email address below and clicking the “Submit” button, you are … a A subset of patients who took TAVALISSE in these studies had a stable response, … Moved Permanently. The document has moved here. A different way to manage chronic ITP. Important Safety Information What is … WebFostamatinib is a drug used to treat adults with low platelet count due to chronic immune thrombocytopenia (ITP) when a prior treatment for ITP has not worked well enough. …
WebFostamatinib disodium C23H36FN6Na2O15P - PubChem Apologies, we are having some trouble retrieving data from our servers... PUGVIEW FETCH ERROR: 403 Forbidden … WebMay 23, 2024 · Fostamatinib disodium hexahydrate (Tavalisse–Rigel) is a phosphate prodrug that, after oral administration, is converted in the gastrointestinal tract to its active metabolite, R406. The new agent is a tyrosine kinase inhibitor and is the first drug with activity against SYK. By inhibiting SYK, the active metabolite reduces antibody-mediated ...
WebApr 30, 2024 · TAVALISSE™ (fostamatinib disodium hexahydrate) tablets is indicated for the treatment of thrombocytopenia in adult patients with chronic immune … WebMar 11, 2024 · The company's first FDA approved product is TAVALISSE ® (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with...
WebFostamatinib (R788) disodium (Tamatinib Fosdium) hexahydrate, a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM in a cell-free assay. R788 is a …
WebFostamatinib disodium (R788) is the oral prodrug of the active compound R406, a relatively selective small molecule inhibitor of Syk. Pre-clinical Pharmacology. R406 is a … see more news about bc to victoria ferryWebFostamatinib has been investigated for the treatment and basic science of Rheumatoid Arthritis and Immune Thrombocytopenic Purpura (ITP). It was approved on April 17, 2024, … see more news about a flesh eating bacteriaWebTAVLESSE 100 mg film-coated tablets Each film-coated tablet contains 126.2 mg of fostamatinib disodium hexahydrate equivalent to 100 mg fostamatinib Excipient(s) with … put in light switchWebApr 17, 2024 · TAVALISSE ™ (fostamatinib disodium hexahydrate) tablets is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an... see more news about boeing navy stingrayput in list pythonWebTAVALISSE ® (fostamatinib disodium hexahydrate) is a selective, oral spleen tyrosine kinase (SYK) inhibitor being evaluated in clinical trials for the treatment of hospitalized … put in loopWebFostamatinib disodium is approved to treat: Thrombocytopenia (low platelet levels). It is used in adults with chronic immune thrombocytopenia (ITP). ITP is a condition in which … putin linked superyacht